Growth Metrics

Dna X (SONM) Change in Account Payables (2018 - 2025)

Dna X filings provide 8 years of Change in Account Payables readings, the most recent being $12.0 million for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 13.2% to $12.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.5 million, a 33.39% decrease, with the full-year FY2025 number at $9.5 million, down 33.39% from a year prior.
  • Change in Account Payables hit $12.0 million in Q4 2025 for Dna X, up from -$175000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $13.8 million in Q4 2024 to a low of -$5.6 million in Q1 2025.
  • Median Change in Account Payables over the past 5 years was $425500.0 (2023), compared with a mean of $1.7 million.
  • The widest YoY moves for Change in Account Payables: up 3769.41% in 2025, down 1128.52% in 2025.
  • Dna X's Change in Account Payables stood at -$3.0 million in 2021, then soared by 386.74% to $8.7 million in 2022, then crashed by 139.22% to -$3.4 million in 2023, then surged by 504.58% to $13.8 million in 2024, then dropped by 13.2% to $12.0 million in 2025.
  • The last three reported values for Change in Account Payables were $12.0 million (Q4 2025), -$175000.0 (Q3 2025), and $3.3 million (Q2 2025) per Business Quant data.